Robert Morgan

Robert Morgan has over 20 years of experience in regulatory affairs, working in various leadership positions. Robert is currently the Vice President of Regulatory Affairs at Purespring Therapeutics, a role they started in October 2021. Prior to that, they served as the Executive Director of Global Regulatory Affairs at Jazz Pharmaceuticals from October 2019 to October 2021. Before that, they were the Executive Director of Regulatory Affairs at NIGHTSTAR THERAPEUTICS from June 2018 to September 2019. Robert also worked at Shire Pharmaceuticals as a Senior Regulatory Affairs Director from September 2006 to May 2018. Robert started their career at GlaxoSmithKline, where they served as a Registration Executive from August 1998 to June 2000. Throughout their career, Robert has also held positions at PAREXEL, AKOS Limited, and Merck Generics.

Robert Morgan completed their education in a chronological order. Robert obtained a BSc(Hons) degree in Biotechnology from London South Bank University, which they attended from 1994 to 1998. Later, from 2003 to 2006, they pursued a Postgraduate Diploma in Regulatory Affairs from the University of Wales, Cardiff.